Vitamin B12 Deficiency in Type 2 Diabetes Patients Using Metformin

Authors

  • Gomaa Sulaiman Department of Dental Technology, Faculty of Medical Technology, The University of Tripoli, Libya.
  • Najua Ferrara Department of Medical Laboratory Sciences, Faculty of Medical Technology, The University of Tripoli, Libya.
  • Ali Elbahi Al-Andalus Diagnostic Centre Lab, Tripoli, Libya. Diabetes and Endocrinology University Hospital Tripoli, Libya
  • Salah Elbaruni Department of Medical Laboratory Sciences, Faculty of Medical Technology, The University of Tripoli, Libya.

Keywords:

T2DM, Metformin, Vitamin B12 Deficiency

Abstract

Background and aims. Metformin is the first line of medical therapy for type 2 diabetes, the mechanism of metformin remains as yet incompletely understood but recent studies have reported a decrease in vitamin B12 in patients treated with metformin. This study was aimed to evaluate vitamin B12 status in type 2 diabetic patients (T2DM) treated with metformin compared to a control group, and also to evaluate the correlation between the vitamin status and the dose, the frequency of taking metformin, as well as with the age. Methods. This was a cross-sectional study conducted in T2DM patients, 150 patients on metformin and 150 patients without metformin (control group). Vitamin B12 analysed using fully automated modular analyser Roche COBAS e411 Immunoassay system, and Snibe MAGLUMI 2000. Results. The average duration of taking metformin is 10.05 +/- 6.58 years and the average dose is 691.30 +/- 198.41 mg/day. The serum level of vitamin B12 (Cobalamin) is significantly lower in patients taking metformin (216.6 pg/ml versus 555.1 pg./ml, p=0.001). About 31 of 150 diabetic patients on metformin (20.67%) presented a vitamin B12 deficiency (level < 200 pg./ml) versus a 7 without metformin (4.67%). Cobalamin deficiency (rate between 200 and 300 pg/ml) was noted in 50 patients (33.33%) of patients on metformin versus 16 (10.67%) without metformin. The current study reported a relationship between metformin and vitamin B12 deficiency in type 2 diabetic patients. Conclusion. Metformin impacted vitamin B12 levels and our recommendations screening test and treatment modalities should be established due to the widespread use of metformin in T2D patients.

Downloads

Published

2023-04-10

How to Cite

1.
Gomaa Sulaiman, Najua Ferrara, Ali Elbahi, Salah Elbaruni. Vitamin B12 Deficiency in Type 2 Diabetes Patients Using Metformin. Alq J Med App Sci [Internet]. 2023 Apr. 10 [cited 2024 Apr. 23];:160-5. Available from: https://journal.utripoli.edu.ly/index.php/Alqalam/article/view/232

Issue

Section

Articles

Most read articles by the same author(s)

Similar Articles

1 2 3 > >> 

You may also start an advanced similarity search for this article.